Quelm is the first platform that fuses your DNA, metabolic patterns, cardiac rhythms, and behavioral science into a single living model of your biology — then acts on it.
GOOD MORNING, JARRAD
Health Intelligence
QTc
412ms
CYP2D6
Ultra-R
MSI
0.82
5-LAYER METABOLIC FORECAST
Three fundamental failures keep precision medicine theoretical instead of practical.
Standard protocols ignore your genetics. A drug that works for 70% of people may be dangerous for you — yet nobody checks before prescribing.
of prescriptions ignore pharmacogenomics
Your CGM data sits in one app. Lab results in another. Wearable metrics in a third. No system connects the dots into a coherent model of you.
average health apps per person
Current health tech tells you what already happened. It doesn’t forecast metabolic crashes, cardiac risks, or circadian misalignment before they occur.
of health issues are caught too late
CYP2D6, CYP3A4, and 7+ pharmacogenomic variants analyzed in real-time. Every medication protocol is personalized to your metabolism — not population averages.
Population baselines, genetic modifiers, EWMA trends, circadian rhythms, and Bayesian priors converge into a single metabolic forecast that sees crashes before they happen.
TTM stage-of-change detection, Fogg micro-habit triggers, and motivational interviewing — adapted to your psychology, not a generic chatbot script.
Continuous cardiac risk assessment during treatment protocols. CYP2D6-aware drug interaction alerts and timeline-based QTc interval tracking.
Nine-domain biological simulation. Run what-if scenarios across metabolic, cardiac, genetic, circadian, and cognitive systems before making real decisions.
On-device ONNX inference. Differential privacy budgets. Your data never leaves your phone, yet the model improves from collective patterns.
CYP2D6, CYP3A4, and 7+ pharmacogenomic variants analyzed in real-time. Every medication protocol is personalized to your metabolism — not population averages.
Population baselines, genetic modifiers, EWMA trends, circadian rhythms, and Bayesian priors converge into a single metabolic forecast that sees crashes before they happen.
TTM stage-of-change detection, Fogg micro-habit triggers, and motivational interviewing — adapted to your psychology, not a generic chatbot script.
Continuous cardiac risk assessment during treatment protocols. CYP2D6-aware drug interaction alerts and timeline-based QTc interval tracking.
Nine-domain biological simulation. Run what-if scenarios across metabolic, cardiac, genetic, circadian, and cognitive systems before making real decisions.
On-device ONNX inference. Differential privacy budgets. Your data never leaves your phone, yet the model improves from collective patterns.
PHARMACOGENOMIC PROFILE
Every number here is verifiable. This isn't a pitch deck — it's a codebase.
Lines of Production Code
Patented Innovations
Patent Claims Filed
Database Tables
Every core system in Quelm is protected by provisional patent filings. This isn't a wrapper around existing APIs — it's novel architecture, built from first principles.
Core engine patents covering pharmacogenomics, metabolic prediction, cardiac safety, and AI coaching architectures.
Digital twin simulation, behavioral phenotyping, federated learning, and treatment readiness qualification systems.
Proprietary algorithms for biological age, gamification, voice biomarkers, and ambient health computing.
Quelm was built under the assumption that health data is the most sensitive data a person owns. Every architectural decision — from on-device inference to federated learning — enforces that principle at the system level, not the policy level.
Business Associate Agreements with every vendor. PHI encrypted AES-256 at rest and TLS 1.3 in transit.
ONNX Runtime inference runs locally on your phone. Sensitive health data is processed without ever leaving the device.
Federated learning with mathematically proven privacy budgets. Population insights improve without exposing individual records.
Facility-scoped access control, JTI token tracking, SSRF protection, and TOCTOU race condition hardening across every endpoint.
The precision medicine market is projected to reach $130B by 2030. Quelm is positioned to capture the intersection of pharmacogenomics, wearable intelligence, and AI-driven health optimization.
Quelm launches with a select group of early adopters. Join the waitlist to reserve your spot.
No spam. Unsubscribe anytime. Your email is never shared.